Tag: Gastroenterology

July 26, 2018

CRH Medical Corporation Announces Majority Acquisition of Lake Washington Anesthesia, PLLC

CRH Medical (TSX:CRH; NYSE:CRHM) has announced it has completed an accretive transaction where it has acquired a 51 percent interest...
April 23, 2018

Big Pharma M&A: Shire Reviews Fourth Acquisition Proposal from Takeda

Takeda Pharmaceuticals may become a top global drugmaker with positions in treatments for cancers, gastrointestinal diseases and nervous-system disorders.
March 28, 2018

Interpace Diagnostics Announces Agreement with Acupath Laboratories

Interpace Diagnostics (NASDAQ:IDXG) a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services...
March 26, 2018

TiGenix and Takeda announce Alofisel (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn’s disease in Europe

TiGenix (NASDAQ: TIG) and Takeda Pharmaceutical (TSE: 4502) announced that the European Commission (EC) has approved Alofisel (darvadstrocel), previously Cx601,...
February 7, 2018

8 Medical Device Stocks on the TSX and TSXV

Here, the Investing News Network looks at publicly traded medical device and technology companies listed on the TSX.
November 16, 2017

GT Biopharma Appoints New President and COO

GT Biopharma announced the appointment of Shawn Cross as president and COO of the company.
August 18, 2017

Ritter Pharmaceuticals Announces Phase 3 Plans for RP-G28

Ritter Pharmaceuticals announced its phase 3 plans after their end-of-phase 2 meeting with the FDA for RP-G28 treating lactose intolerance.